Retraction Note to: Cell Death and Disease https://doi.org/10.1038/cddis.2017.335, published online 20 July 2017
The Editors have retracted this article. Following publication, concerns have been identified with the figures in this article, specifically:
-
In Figure 2a, the 96H [DMSO] panel appears to be a 180 degree rotation of the 72H [DMSO] panel.
-
In Figure 2b, the SMMC-7721 beta-actin bands in the 96H treatment appear to be a flipped and widened version of the 72H treatment in the same panel; also the Hep G2 beta-actin bands in the 96H treatment appear to be a flipped and widened version of the 72H treatment in the same panel.
-
In Figure 8f, the lower section of the HNF-4alpha [control] panel appears to be identical to the upper section of the HNF-4alpha [OA[75 mh/kg)] panel.
The Editors therefore no longer have confidence in the data.
Author Qinglong Guo does not agree to this retraction. Authors Libin Wei, Yuanyuan Dai, Yuxin Zhou, Zihao He, Jingyue Yao, Li Zhao and Lin Yang have not responded to correspondence from the editor or publisher about this retraction.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Wei, L., Dai, Y., Zhou, Y. et al. Retraction Note: Oroxylin A activates PKM1/HNF4 alpha to induce hepatoma differentiation and block cancer progression. Cell Death Dis 16, 167 (2025). https://doi.org/10.1038/s41419-025-07496-1
Published:
Version of record:
DOI: https://doi.org/10.1038/s41419-025-07496-1
